The information highlighted (if any) are the most recent updates for this brand.
VPRIV is indicated for long-term enzyme replacement therapy (ERT) for patients with Gaucher disease. VPRIV is indicated for the improvement of symptoms of Gaucher disease (Anemia, thrombocytopenia, hepatomegaly and splenomegaly, and bone manifestation).